{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:05:33Z","timestamp":1793171133428,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["CIPROM\/2023\/25"],"award-info":[{"award-number":["CIPROM\/2023\/25"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["FPU231\/04360"],"award-info":[{"award-number":["FPU231\/04360"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science Innovation and Universities","doi-asserted-by":"publisher","award":["PDC2022\\u2013133952\\u2013100"],"award-info":[{"award-number":["PDC2022\\u2013133952\\u2013100"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science Innovation and Universities","doi-asserted-by":"publisher","award":["PID2022- 141606OB-I00"],"award-info":[{"award-number":["PID2022- 141606OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.compbiolchem.2025.108788","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:22:41Z","timestamp":1763637761000},"page":"108788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Computational modeling of anti-VEGFA drug interactions with VEGF-A: Insights into therapeutic strategies for neovascular AMD"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5908-8092","authenticated-orcid":false,"given":"\u00c1ngel","family":"Parra-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Rom\u00e1n-Vallina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Mart\u00ednez-Navarrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.compbiolchem.2025.108788_bib1","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1007\/s00417-024-06531-9","article-title":"Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes","volume":"262","author":"Agostini","year":"2024","journal-title":"Graefe\u2019S. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.compbiolchem.2025.108788_bib2","first-page":"1","article-title":"Computational analysis of bevacizumab binding with protein receptors for its potential anticancer activity","author":"Alsakhen","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"W1","key":"10.1016\/j.compbiolchem.2025.108788_bib3","doi-asserted-by":"crossref","first-page":"W344","DOI":"10.1093\/nar\/gkw408","article-title":"ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules","volume":"44","author":"Ashkenazy","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.compbiolchem.2025.108788_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.oret.2025.01.011","article-title":"Macular atrophy in neovascular age-related macular degeneration","volume":"9","author":"Berni","year":"2025","journal-title":"Ophthalmol. Retin."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108788_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09654-8","article-title":"Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology","volume":"7","author":"Bertoni","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.compbiolchem.2025.108788_bib6","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.ophtha.2017.05.035","article-title":"Prevalence of age-related macular degeneration in Europe","volume":"124","author":"Colijn","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.compbiolchem.2025.108788_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.21037\/aes-21-45","article-title":"A narrative review on the role of abicipar in age-related macular degeneration","volume":"6","author":"Ghahvechian","year":"2021","journal-title":"Ann. Eye Sci."},{"issue":"S1","key":"10.1016\/j.compbiolchem.2025.108788_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/elps.200900140","article-title":"Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective","volume":"30","author":"Guex","year":"2009","journal-title":"ELECTROPHORESIS"},{"issue":"43","key":"10.1016\/j.compbiolchem.2025.108788_bib9","doi-asserted-by":"crossref","first-page":"15447","DOI":"10.1073\/pnas.0505425102","article-title":"Conservation and relative importance of residues across protein-protein interfaces","volume":"102","author":"Guharoy","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.compbiolchem.2025.108788_bib10","unstructured":"Hern\u00e1ndez-Ayala, L. 2023. Simulaciones prote\u00edna-ligando con ligandos co-cristalizados: Gu\u00eda para realizar \u201cre-docking.\u201d"},{"key":"10.1016\/j.compbiolchem.2025.108788_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.729513","article-title":"Structural biology in the clouds: the WeNMR-EOSC ecosystem","volume":"8","author":"Honorato","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"11","key":"10.1016\/j.compbiolchem.2025.108788_bib12","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2.4 web server for integrative modeling of biomolecular complexes","volume":"19","author":"Honorato","year":"2024","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108788_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","article-title":"Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108788_bib14","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Rom. J. Morphol. Embryol. = Rev. Roum. De. Morphol. Et. Embryol."},{"issue":"6","key":"10.1016\/j.compbiolchem.2025.108788_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/eye.2011.66","article-title":"Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab","volume":"25","author":"Meyer","year":"2011","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108788_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","article-title":"Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab","volume":"15","author":"Papadopoulos","year":"2012","journal-title":"Angiogenesis"},{"key":"10.1016\/j.compbiolchem.2025.108788_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125379","article-title":"A novel bevacizumab delivery system using solid lipid nanoparticles for potential wet age-related macular degeneration treatment: an in vivo study","volume":"673","author":"Parra-S\u00e1nchez","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"13","key":"10.1016\/j.compbiolchem.2025.108788_bib18","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108788_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00248","article-title":"Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach","volume":"6","author":"Platania","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiolchem.2025.108788_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.945808","article-title":"Antibody-antigen binding interface analysis in the big data era","volume":"9","author":"Reis","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"15","key":"10.1016\/j.compbiolchem.2025.108788_bib21","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1167\/iovs.18-25307","article-title":"Functional characterization of abicipar-pegol, an anti-VEGF DARPin therapeutic that potently inhibits angiogenesis and vascular permeability","volume":"59","author":"Rodrigues","year":"2018","journal-title":"Investig. Opthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.compbiolchem.2025.108788_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1167\/tvst.11.10.36","article-title":"Evaluation of molecular properties versus in vivo performance of aflibercept, brolucizumab, and ranibizumab in a retinal vascular hyperpermeability model","volume":"11","author":"Schubert","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"4587","key":"10.1016\/j.compbiolchem.2025.108788_bib23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108788_bib24","first-page":"50","article-title":"Molecular dynamic stability study of VEGF inhibitor in patients with bladder cancer","volume":"33","author":"Siregar","year":"2025","journal-title":"Acta Inform. Med. AIM J. Soc. Med. Inform. Bosnia Herzeg. Cas. Drustva Za Med. Inform. BiH."},{"issue":"9","key":"10.1016\/j.compbiolchem.2025.108788_bib25","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/bjophthalmol-2011-300654","article-title":"Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug","volume":"96","author":"Stewart","year":"2012","journal-title":"Br. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.compbiolchem.2025.108788_bib26","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/bioinformatics\/btz828","article-title":"QMEANDisCo\u2014distance constraints applied on model quality estimation","volume":"36","author":"Studer","year":"2020","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108788_bib27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/CS20040370","article-title":"The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions","volume":"109","author":"Takahashi","year":"2005","journal-title":"Clin. Sci."},{"key":"10.1016\/j.compbiolchem.2025.108788_bib28","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.07454","article-title":"Contacts-based prediction of binding affinity in protein\u2013protein complexes","volume":"4","author":"Vangone","year":"2015","journal-title":"eLife"},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108788_bib29","article-title":"PRODIGY: a contact-based predictor of binding affinity in protein-protein complexes","volume":"7","author":"Vangone","year":"2017","journal-title":"BIOProtoc."},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108788_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.15446\/rev.colomb.quim.v50n3.97430","article-title":"Acoplamiento molecular y modelado tridimensional por homolog\u00eda de flavonoides derivados de amentoflavona con las neuraminidasas H1N1 y H5N1 del virus de gripe aviar","volume":"50","author":"Vivas Reyes","year":"2022","journal-title":"Rev. Colomb. De. Qu\u00edmica"},{"issue":"231","key":"10.1016\/j.compbiolchem.2025.108788_bib31","article-title":"Evaluation of Faricimab binding affinity, chemical stability and sterility after compounding and storage in two different polypropylene syringes","volume":"65","author":"Waldstein","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1961","key":"10.1016\/j.compbiolchem.2025.108788_bib32","article-title":"Analysis of the binding affinity of vascular endothelial growth factor A (VEGF) to ranibizumab, aflibercept and bevacizumab","volume":"54","author":"Wang","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"W1","key":"10.1016\/j.compbiolchem.2025.108788_bib33","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"23","key":"10.1016\/j.compbiolchem.2025.108788_bib34","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","article-title":"PRODIGY: a web server for predicting the binding affinity of protein\u2013protein complexes","volume":"32","author":"Xue","year":"2016","journal-title":"Bioinformatics"},{"issue":"10","key":"10.1016\/j.compbiolchem.2025.108788_bib35","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1021\/mp500160v","article-title":"Comparison of binding characteristics and in vitro activities of three inhibitors of vascular endothelial growth factor A","volume":"11","author":"Yang","year":"2014","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108788_bib36","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/s41598-024-52942-3","article-title":"Efficacy and safety of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review and meta-analysis","volume":"14","author":"Yen","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125004505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125004505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:01:23Z","timestamp":1778616083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927125004505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":36,"alternative-id":["S1476927125004505"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108788","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational modeling of anti-VEGFA drug interactions with VEGF-A: Insights into therapeutic strategies for neovascular AMD","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108788"}}